MICROSPORIDIA INFECTION

MICROSPORIDIA INFECTION was reported 351 times

These drug classes are most commonly taken by patients reporting MICROSPORIDIA INFECTION:

# Drug Count
0 Corticosteroid [EPC] 254
1 Kinase Inhibitor [EPC] 94
2 Azole Antifungal [EPC] 82
3 Alkylating Drug [EPC] 77
4 CD52-directed Cytolytic Antibody [EPC] 64
5 CD20-directed Cytolytic Antibody [EPC] 61
6 mTOR Inhibitor Immunosuppressant [EPC] 39
7 Insulin Analog [EPC] 38
8 Loop Diuretic [EPC] 38
9 Interleukin-2 Receptor Blocking Antibody [EPC] 37
10 Vitamin D3 Analog [EPC] 37
11 Folate Analog Metabolic Inhibitor [EPC] 36
12 Standardized Chemical Allergen [EPC] 35
13 Xanthine Oxidase Inhibitor [EPC] 33
14 Antiprotozoal [EPC] 31
15 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 31
16 Sulfonamide Antimicrobial [EPC] 31
17 alpha-Adrenergic Blocker [EPC] 31
18 beta-Adrenergic Blocker [EPC] 31
19 Calcineurin Inhibitor Immunosuppressant [EPC] 24
20 Calcium Channel Blocker [EPC] 23
21 Dihydropyridine Calcium Channel Blocker [EPC] 23
22 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 18
23 Antimetabolite Immunosuppressant [EPC] 17
24 Antirheumatic Agent [EPC] 17
25 Tumor Necrosis Factor Blocker [EPC] 13
26 Immunoglobulin G [EPC] 12
27 Proteasome Inhibitor [EPC] 11
28 Purine Antimetabolite [EPC] 11
29 Nucleoside Metabolic Inhibitor [EPC] 10
30 Anthelmintic [EPC] 8
31 Proton Pump Inhibitor [EPC] 8
32 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7
33 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7
34 Platinum-based Drug [EPC] 7
35 Topoisomerase Inhibitor [EPC] 7
36 Erythropoiesis-stimulating Agent [EPC] 6
37 Nucleoside Analog Antiviral [EPC] 6
38 RANK Ligand Inhibitor [EPC] 6
39 Lipid-based Polyene Antifungal [EPC] 5
40 Osmotic Laxative [EPC] 5
41 Polyene Antifungal [EPC] 5
42 Aminoglycoside Antibacterial [EPC] 4
43 Insulin [EPC] 4
44 Macrolide Antimicrobial [EPC] 4
45 Rifamycin Antimycobacterial [EPC] 4
46 Antimycobacterial [EPC] 3
47 Janus Kinase Inhibitor [EPC] 3
48 Protease Inhibitor [EPC] 3
49 Provitamin D2 Compound [EPC] 3
50 Acetylcholine Release Inhibitor [EPC] 2
51 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2
52 Cytochrome P450 3A Inhibitor [EPC] 2
53 Fluoroquinolone Antibacterial [EPC] 2
54 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
55 Human Immunoglobulin G [EPC] 2
56 Neuromuscular Blocker [EPC] 2
57 Sulfonamide Antibacterial [EPC] 2
58 BCL-2 Inhibitor [EPC] 1
59 CD19-directed Chimeric Antigen Receptor [EPC] 1
60 CD38-directed Cytolytic Antibody [EPC] 1
61 Cannabinoid [EPC] 1
62 Echinocandin Antifungal [EPC] 1
63 Factor Xa Inhibitor [EPC] 1
64 Genetically-modified Autologous T Cells [EPC] 1
65 Histamine-2 Receptor Antagonist [EPC] 1
66 Integrin Receptor Antagonist [EPC] 1
67 Interleukin-6 Receptor Antagonist [EPC] 1
68 Microtubule Inhibitor [EPC] 1
69 Nitroimidazole Antimicrobial [EPC] 1
70 Nonsteroidal Anti-inflammatory Drug [EPC] 1
71 Oxazolidinone Antibacterial [EPC] 1
72 Penem Antibacterial [EPC] 1
73 Platelet Aggregation Inhibitor [EPC] 1
74 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
75 Quinolone Antimicrobial [EPC] 1
76 Sulfonylurea [EPC] 1
77 Tetracycline-class Drug [EPC] 1
78 Thalidomide Analog [EPC] 1